A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

TY - JOUR

T1 - A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

AU - Suarez-Kelly, Lorena P.

AU - Levine, Kala M.

AU - Olencki, Thomas E.

AU - del Campo, Sara E.Martin

AU - Streacker, Elizabeth A.

AU - Brooks, Taylor R.

AU - Karpa, Volodymyr I.

AU - Markowitz, Joseph

AU - Bingman, Anissa K.

AU - Geyer, Susan M.

AU - Kendra, Kari L.

AU - Carson, William E.

N1 - Funding Information: Author contributions Authors TEO, SEMC, JM, KLK, and WEC were involved in the study conception and design. Collection and assembly of data was conducted by LPS, KML, SEMC, EAS, TRB, VIK, JM, and AKB. Authors LPS, KML, TEO, JM, AKB, SMG, KLK, and WEC were involved in data analysis and interpretation. Administrative support was provided by LPS and WEC. Provision of study material or patients was performed by TEO, KLK, and WEC. LPS, KML, SEMC, EAS, JM, SMG, and WEC were involved in manuscript writing. All authors approved the final version of the manuscript.

PY - 2019/4/2

Y1 - 2019/4/2

UR - https://www.scopus.com/pages/publications/85063984284

U2 - 10.1007/s00262-019-02308-w

DO - 10.1007/s00262-019-02308-w

M3 - Article

C2 - 30725205

AN - SCOPUS:85063984284

SN - 0340-7004

VL - 68

SP - 619

EP - 629

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

IS - 4

ER -